This index tracks all the U.S. healthcare equities in the broader mid-cap based S&P 400 index.
This index tracks all the U.S. healthcare equities in the broader mid-cap based S&P 400 index.
Mutual Fund to ETF Converter Tool
We’re sorry, there are no active ETFs associated with this index.
Sort By:
ETF Database staff has allocated each ETF in the ETF database, as well as each index, to a single ‘best-fit’ ETF Database Category. Other ETFs in the Health & Biotech Equities ETF Database Category are presented in the following table.
* Assets in thousands of U.S. Dollars.
Historical return data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Fund flow information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Expense information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Dividend information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Holdings data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Tax Rate data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Technical information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to analysis of other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to a proprietary ETF Database rating for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
| Symbol | ETF Name | Asset Class | Total Assets* | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | YTD FF | 1 Week FF | 4 Week FF | 1 Year FF | 3 Year FF | 5 Year FF | ETF Database | Inception | ER | Commission Free | Annual Dividend Rate | Dividend Date | Dividend | Annual Dividend Yield % | P/E Ratio | Beta | # of Holdings | % In Top 10 | Complete | ST Cap Gain Rate | LT Cap Gain Rate | Tax Form | Lower Bollinger | Upper Bollinger | Support 1 | Resistance 1 | RSI | Advanced | Fact Sheet | ETF Holdings | Chart | ETF Home Page | Head-To-Head | Liquidity Rating | Expenses Rating | Returns Rating | Volatility Rating | Dividend Rating | Concentration Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | Equity | $42,461,900 | 7.1% | 10,177,135.0 | $164.44 | 1.53% | 3.6% | 7.9% | 24.5% | 9.8% | 6.8% | Health & Biotech Equities | 1998-12-16 | 0.08% | N/A | $2.53 | 2026-06-22 | $0.66 | 1.54% | 18.2 | 0.56 | 62 | 61.4% | View | 40% | 20% | 1099 | $146.36 | $164.42 | $163.68 | $165.40 | 68.04 | View | View | View | View | View | View | A | A | |||||||||||
| VHT | Vanguard Health Care ETF | Equity | $18,267,000 | 8.6% | 236,165.0 | $310.29 | 1.47% | 3.8% | 9.6% | 27.5% | 10.6% | 5.9% | Health & Biotech Equities | 2004-01-26 | 0.09% | Vanguard | $4.72 | 2026-06-24 | $0.99 | 1.52% | 27.3 | 0.60 | 427 | 51.7% | View | 40% | 20% | 1099 | $272.47 | $310.26 | $309.19 | $311.53 | 70.68 | View | View | View | View | View | View | A | A | |||||||||||
| XBI | State Street SPDR S&P Biotech ETF | Equity | $10,861,400 | 34.5% | 8,809,170.0 | $163.87 | 1.90% | 3.6% | 27.5% | 97.0% | 26.4% | 4.3% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.57 | 2026-06-22 | $0.14 | 0.35% | 19.1 | 0.82 | 152 | 13.1% | View | 40% | 20% | 1099 | $122.63 | $168.25 | $160.70 | $165.70 | 74.24 | View | View | View | View | View | View | A+ | A | |||||||||||
| IBB | iShares Biotechnology ETF | Equity | $9,510,030 | 17.6% | 1,484,768.0 | $198.23 | 1.50% | 4.2% | 17.7% | 55.1% | 16.8% | 4.3% | Health & Biotech Equities | 2001-02-05 | 0.44% | N/A | $0.41 | 2026-06-15 | $0.02 | 0.21% | 23.2 | 0.70 | 242 | 45.1% | View | 40% | 20% | 1099 | $160.16 | $199.50 | $196.14 | $199.51 | 75.07 | View | View | View | View | View | View | A | B | |||||||||||
| IXJ | iShares Global Healthcare ETF | Equity | $4,084,420 | 5.2% | 224,235.0 | $101.61 | 1.14% | 3.3% | 7.2% | 20.5% | 8.6% | 5.3% | Health & Biotech Equities | 2001-11-13 | 0.40% | N/A | $1.44 | 2026-06-15 | $0.85 | 1.42% | 24.8 | 0.57 | 112 | 47.7% | View | 40% | 20% | 1099 | $91.41 | $101.65 | $101.21 | $102.10 | 66.46 | View | View | View | View | View | View | A | B+ | |||||||||||
| FHLC | Fidelity MSCI Health Care Index ETF | Equity | $3,298,190 | 8.6% | 206,732.0 | $80.15 | 1.42% | 3.8% | 9.5% | 27.7% | 10.5% | 5.9% | Health & Biotech Equities | 2013-10-21 | 0.08% | Fidelity | $1.02 | 2026-06-18 | $0.26 | 1.27% | 26.8 | 0.60 | 334 | 52.1% | View | 40% | 20% | 1099 | $70.43 | $80.15 | $79.88 | $80.47 | 70.75 | View | View | View | View | View | View | A | A+ | |||||||||||
| IYH | iShares U.S. Healthcare ETF | Equity | $3,239,410 | 7.5% | 734,967.0 | $69.57 | 1.46% | 3.8% | 8.6% | 25.2% | 9.4% | 5.8% | Health & Biotech Equities | 2000-06-12 | 0.38% | N/A | $0.80 | 2026-06-15 | $0.16 | 1.15% | 26.8 | 0.58 | 102 | 59.2% | View | 40% | 20% | 1099 | $61.40 | $69.56 | $69.29 | $69.89 | 68.93 | View | View | View | View | View | View | B+ | B+ | |||||||||||
| IHI | iShares U.S. Medical Devices ETF | Equity | $3,206,110 | -15.7% | 2,703,965.0 | $52.25 | 0.27% | 5.8% | 4.5% | -14.8% | -1.3% | -2.8% | Health & Biotech Equities | 2006-05-01 | 0.38% | N/A | $0.24 | 2026-06-15 | $0.08 | 0.46% | 29.4 | 0.82 | 48 | 74.9% | View | 40% | 20% | 1099 | $48.11 | $52.08 | $51.80 | $52.95 | 57.78 | View | View | View | View | View | View | A | A- | |||||||||||
| FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | $2,874,510 | 24.0% | 60,560.0 | $256.19 | 0.23% | 3.4% | 15.0% | 58.1% | 19.6% | 8.7% | Health & Biotech Equities | 2006-06-19 | 0.55% | N/A | $0.00 | 2024-12-13 | $1.17 | 0.00% | 27.3 | 0.65 | 31 | 43.0% | View | 40% | 20% | 1099 | $213.40 | $259.53 | $254.58 | $257.89 | 78.07 | View | View | View | View | View | View | B+ | B- | |||||||||||
| ARKG | ARK Genomic Revolution ETF | Equity | $1,737,650 | 47.0% | 3,150,741.0 | $42.60 | -2.23% | 1.3% | 27.5% | 75.0% | 9.4% | -13.9% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | N/A | 1.69 | 33 | 60.6% | View | 40% | 20% | 1099 | $30.34 | $45.39 | $41.71 | $43.72 | 70.94 | View | View | View | View | View | View | A | C+ | |||||||||||
| Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More | ||||||||||||||||||||||||||||||||||||||||||||||||||||
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...